Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.0060 AUD
Change Today 0.00 / 0.00%
Volume 250.0K
As of 8:06 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaust ltd (PAA) Snapshot

Open
A$0.0060
Previous Close
A$0.0060
Day High
A$0.0060
Day Low
A$0.0060
52 Week High
04/7/15 - A$0.02
52 Week Low
01/29/15 - A$0.0060
Market Cap
11.0M
Average Volume 10 Days
2.0M
EPS TTM
A$-0.0017
Shares Outstanding
1.8B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMAUST LTD (PAA)

Related News

No related news articles were found.

pharmaust ltd (PAA) Related Businessweek News

No Related Businessweek News Found

pharmaust ltd (PAA) Details

PharmAust Limited, through its subsidiaries, operates as a drug discovery and development company primarily in Australia and Switzerland. It provides products and services in synthetic and medicinal chemistry on a contract basis for the drug discovery and pharmaceutical industries. The company’s products include a range of pharmaceutical impurities, degradants, and metabolites of active ingredients and excipients primarily for OTC and generic drugs. It also focuses on developing a drug discovery intellectual property for the treatment of various types of cancers in humans and animals. The company is based in Nedlands, Australia.

pharmaust ltd (PAA) Top Compensated Officers

Executive Chairman
Total Annual Compensation: A$231.7K
Executive Director
Total Annual Compensation: A$69.3K
Compensation as of Fiscal Year 2014.

pharmaust ltd (PAA) Key Developments

David Morris to Retire as Director of PharmAust Limited

Professor David Morris, a Non-Executive Director of PharmAust Limited has advised the board that he intends to retire a as a director of the company, effective from the close of the Annual General Meeting.

PharmAust Limited Announces Cash Flow Results for the Third Quarter and Nine Months Ended March 31, 2015

PharmAust Limited announced cash flow results for the third quarter and nine months ended March 31, 2015. For the quarter, the company reported net operating cash out flows of AUD 88,000. For the nine months, the company reported net operating cash out flows of AUD 1,149,000.

PharmAust Limited, Special/Extraordinary Shareholders Meeting, May 26, 2015

PharmAust Limited, Special/Extraordinary Shareholders Meeting, May 26, 2015., at 12:00 E. Australia Standard Time. Location: Blue Ocean Equities. Agenda: To consider the ratification of tranche one placement shares; and to consider issue of tranche two placement shares.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PAA:AU A$0.01 AUD 0.00

PAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PAA.
View Industry Companies
 

Industry Analysis

PAA

Industry Average

Valuation PAA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.5x
Price/Book 0.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAUST LTD, please visit www.pharmaust.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.